Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Gains from Investment Securities (2017 - 2025)

Catheter Precision has reported Gains from Investment Securities over the past 9 years, most recently at -$109000.0 for Q4 2025.

  • Quarterly Gains from Investment Securities fell 219.78% to -$109000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$15000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $17.0 for FY2025, 99.54% down from the prior year.
  • Gains from Investment Securities was -$109000.0 for Q4 2025 at Catheter Precision, down from $19987.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $214.7 million in Q3 2023 and troughed at -$109000.0 in Q4 2025.
  • The 5-year median for Gains from Investment Securities is $29614.0 (2021), against an average of $12.8 million.
  • Year-over-year, Gains from Investment Securities soared 15042086.41% in 2023 and then tumbled 219.78% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $29614.0 in 2021, then tumbled by 96.66% to $990.0 in 2022, then surged by 2068.18% to $21465.0 in 2023, then skyrocketed by 323.95% to $91000.0 in 2024, then tumbled by 219.78% to -$109000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Gains from Investment Securities are -$109000.0 (Q4 2025), $19987.0 (Q3 2025), and $500000.0 (Q2 2025).